www.cytivalifesciences.com Open in urlscan Pro
172.64.152.91  Public Scan

Submitted URL: https://informmeddireng.com/c/1855393/8d5802a80f679d0a/1
Effective URL: https://www.cytivalifesciences.com/en/gb
Submission: On July 02 via manual from GB — Scanned from GB

Form analysis 1 forms found in the DOM

POST /gb

<form action="/gb" id="__AjaxAntiForgeryForm" method="post"><input name="__RequestVerificationToken" type="hidden" value="lWIZDu0C3kNzJMvc8SezbpKznrxoh8LRAcUUrXIoKqv8HeXf4VOWRpriE0q-D7cWqa3bICzl4ulYs9raE-gO-rgtXdk1"></form>

Text Content

Clear

SearchLoading

Quotes
0

0
Cart
0

0
 * Products
   
 * Applications
   
 * Service & Support
   
 * Resources
   
 * Our Company
   
   
 * 

Quick Order
Track Order
Register/Log in





SCALE RIGHT THE FIRST TIME


HARNESS THE POWER OF DIGITAL SOLUTIONS TO MINIMIZE RISK

Explore Bioreactor Scaler

Which type of workflow are you interested in?
mAbs
mRNA
Cell therapy manufacturing
Viral vectors


KNOWLEDGE AT YOUR FINGERTIPS

Visit our knowledge center for insights that will help you advance your work

Discover now


RESEARCH AND INDUSTRY JOIN FORCES AS MODALITIES MERGE

How will the era of creativity play out for advanced therapies?

Read more


TRENDS IN IMMUNODIAGNOSTICS

From nanoparticles to AI, novel technologies are shaping the future

Learn how


RECENT NEWS


PIERRE-ALAIN RUFFIEUX JOINS CYTIVA AS CHIEF OPERATING OFFICER





CYTIVA’S LATEST INNOVATION SIGNIFICANTLY IMPROVES FILTRATION OF HIGH
CONCENTRATION BIOLOGICS





INNOVATION AND AUTOMATION ARE DRIVING FORCES BEHIND NEXT GENERATION CELL THERAPY
MANUFACTURING PLATFORM FROM CYTIVA





CYTIVA CONTINUES ITS SUPPORT FOR N-LOREM FOUNDATION





RIBOBAY PHARMA BOOSTS CRDMO OFFERINGS WITH CYTIVA’S FIRST FLEXFACTORY PLATFORM
FOR OLIGONUCLEOTIDES





CYTIVA INTRODUCES NEW CELL LINES TO MEET THE CHALLENGES AND INCREASING DEMAND OF
VIRAL VECTOR MANUFACTURING





加速本土化,CYTIVA重磅发布国产标准化ÄKTA READY EXTENDED一次性层析系统





AGC BIOLOGICS SELECTS CYTIVA TO PROVIDE FLEXFACTORY PLATFORMS IN NEW
BIOMANUFACTURING FACILITY IN JAPAN





CYTIVA UNVEILS LATEST INNOVATION FOR LARGE SCALE MAB, VACCINE, AND ADVANCED
THERAPY MANUFACTURING PROCESSES - THE XCELLEREX COMPACT SINGLE-USE MAGNETIC
MIXING SYSTEM




 * 
 * 
 * 
   




Read more



CAREERS

Explore opportunities to work with our extraordinary team

SERVICE & SUPPORT

Find online tools, product documentation and service support

E-LEARNING

Build your skills and continue your education with our eLearning courses

CONTACT US

Customer service, orders, scientific and technical questions

Shop our products
 * How to shop with us
 * Find products
 * Redeem your quote
 * Special offers
 * Track order
 * Shipping information
 * Returns
 * Remanufactured products
 * Find a distributor
   

Applications
 * Bioprocessing
 * Cell and gene therapy
 * Diagnostics
 * Emerging biotech
 * Enterprise solutions
 * Genomics
 * Lab filtration
 * Medical
 * Protein research
   

Support
 * LifeCycle support solutions
 * Regulatory support
 * Change Control Notifications
 * Scientific support
 * Certificate search
 * Handbooks
 * Instructions for use
 * Safety data sheets/SDS
 * Tools and calculators
 * Training
   

Our company
 * About us
 * News center
 * Careers
 * Behind Biopharma
 * Sustainability
 * Contact us
   

United Kingdom

--------------------------------------------------------------------------------

 * © 2024 Cytiva
 * Terms·
   
 * Privacy·
   
 * Cookies·
   
 * Trademarks·
   
 * Preferences·
   
   

 * 
 * 
 * 
 * 
   




WHY AM I ON CYTIVA.COM?




On May 1 the biotechnology, laboratory and medical businesses of Pall
Corporation became part of Cytiva. You'll now find the same great Pall products
and content hosted here.

Continue
Learn more



YOUR PRIVACY

We use cookies to improve your experience on our website and to show you
personalized content. You can allow all, or control these by clicking 'Manage
cookies'.
Reject all Allow cookies
Manage cookies


x